These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 14633713

  • 1. Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model.
    Satoh T, Saika T, Ebara S, Kusaka N, Timme TL, Yang G, Wang J, Mouraviev V, Cao G, Fattah el MA, Thompson TC.
    Cancer Res; 2003 Nov 15; 63(22):7853-60. PubMed ID: 14633713
    [Abstract] [Full Text] [Related]

  • 2. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.
    Nasu Y, Bangma CH, Hull GW, Lee HM, Hu J, Wang J, McCurdy MA, Shimura S, Yang G, Timme TL, Thompson TC.
    Gene Ther; 1999 Mar 15; 6(3):338-49. PubMed ID: 10435084
    [Abstract] [Full Text] [Related]

  • 3. Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.
    Fujita T, Timme TL, Tabata K, Naruishi K, Kusaka N, Watanabe M, Abdelfattah E, Zhu JX, Ren C, Ren C, Yang G, Goltsov A, Wang H, Vlachaki MT, Teh BS, Butler EB, Thompson TC.
    Gene Ther; 2007 Feb 15; 14(3):227-36. PubMed ID: 17024109
    [Abstract] [Full Text] [Related]

  • 4. Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model.
    Saika T, Satoh T, Kusaka N, Ebara S, Mouraviev VB, Timme TL, Thompson TC.
    Cancer Gene Ther; 2004 May 15; 11(5):317-24. PubMed ID: 15044961
    [Abstract] [Full Text] [Related]

  • 5. Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer.
    Nasu Y, Bangma CH, Hull GW, Yang G, Wang J, Shimura S, McCurdy MA, Ebara S, Lee HM, Timme TL, Thompson TC.
    Prostate Cancer Prostatic Dis; 2001 May 15; 4(1):44-55. PubMed ID: 12497062
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer.
    Tabata K, Watanabe M, Naruishi K, Edamura K, Satoh T, Yang G, Abdel Fattah E, Wang J, Goltsov A, Floryk D, Soni SD, Kadmon D, Thompson TC.
    Prostate Cancer Prostatic Dis; 2009 May 15; 12(3):301-9. PubMed ID: 19104507
    [Abstract] [Full Text] [Related]

  • 7. Prostate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines.
    Hull GW, Mccurdy MA, Nasu Y, Bangma CH, Yang G, Shimura S, Lee HM, Wang J, Albani J, Ebara S, Sato T, Timme TL, Thompson TC.
    Clin Cancer Res; 2000 Oct 15; 6(10):4101-9. PubMed ID: 11051263
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model.
    Saika T, Kusaka N, Mouraviev V, Satoh T, Kumon H, Timme TL, Thompson TC.
    Cancer Gene Ther; 2006 Jan 01; 13(1):91-8. PubMed ID: 16052232
    [Abstract] [Full Text] [Related]

  • 9. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors.
    Addison CL, Bramson JL, Hitt MM, Muller WJ, Gauldie J, Graham FL.
    Gene Ther; 1998 Oct 01; 5(10):1400-9. PubMed ID: 9930346
    [Abstract] [Full Text] [Related]

  • 10. Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors.
    Raja Gabaglia C, Diaz de Durana Y, Graham FL, Gauldie J, Sercarz EE, Braciak TA.
    Cancer Res; 2007 Mar 01; 67(5):2290-7. PubMed ID: 17332360
    [Abstract] [Full Text] [Related]

  • 11. Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer.
    Naruishi K, Timme TL, Kusaka N, Fujita T, Yang G, Goltsov A, Satoh T, Ji X, Tian W, Abdelfattah E, Men T, Watanabe M, Tabata K, Thompson TC.
    Cancer Gene Ther; 2006 Jul 01; 13(7):658-63. PubMed ID: 16485011
    [Abstract] [Full Text] [Related]

  • 12. Antitumor mechanism of intratumoral injection with IL-12-expressing adenoviral vector against IL-12-unresponsive tumor.
    Kanagawa N, Gao JQ, Motomura Y, Yanagawa T, Mukai Y, Yoshioka Y, Okada N, Nakagawa S.
    Biochem Biophys Res Commun; 2008 Aug 08; 372(4):821-5. PubMed ID: 18519033
    [Abstract] [Full Text] [Related]

  • 13. Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model.
    Tabata K, Kurosaka S, Watanabe M, Edamura K, Satoh T, Yang G, Abdelfattah E, Wang J, Goltsov A, Floryk D, Thompson TC.
    Gene Ther; 2011 Oct 08; 18(10):969-78. PubMed ID: 21512508
    [Abstract] [Full Text] [Related]

  • 14. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 08; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-12 transduced dendritic cells induce regression of established murine neuroblastoma.
    Shimizu T, Berhanu A, Redlinger RE, Watkins S, Lotze MT, Barksdale EM.
    J Pediatr Surg; 2001 Aug 08; 36(8):1285-92. PubMed ID: 11479878
    [Abstract] [Full Text] [Related]

  • 16. Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice.
    Zhang F, Lu W, Dong Z.
    Clin Cancer Res; 2002 Sep 08; 8(9):2942-51. PubMed ID: 12231540
    [Abstract] [Full Text] [Related]

  • 17. Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity.
    Tatsumi T, Takehara T, Yamaguchi S, Sasakawa A, Miyagi T, Jinushi M, Sakamori R, Kohga K, Uemura A, Ohkawa K, Storkus WJ, Hayashi N.
    Gene Ther; 2007 Jun 08; 14(11):863-71. PubMed ID: 17344900
    [Abstract] [Full Text] [Related]

  • 18. Intratumoral injection of dendritic cells transduced by an SV40-based vector expressing interleukin-15 induces curative immunity mediated by CD8+ T lymphocytes and NK cells.
    Vera M, Razquin N, Prieto J, Melero I, Fortes P, González-Aseguinolaza G.
    Mol Ther; 2005 Nov 08; 12(5):950-9. PubMed ID: 15921960
    [Abstract] [Full Text] [Related]

  • 19. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta.
    Dong Z, Greene G, Pettaway C, Dinney CP, Eue I, Lu W, Bucana CD, Balbay MD, Bielenberg D, Fidler IJ.
    Cancer Res; 1999 Feb 15; 59(4):872-9. PubMed ID: 10029078
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic immune response induced by intratumoral expression of the fusogenic membrane protein of vesicular stomatitis virus and cytokines encoded by adenoviral vectors.
    Hoffmann D, Bayer W, Wildner O.
    Int J Mol Med; 2007 Nov 15; 20(5):673-81. PubMed ID: 17912460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.